Semalytix, a life science startup based in Bielefeld, has announced the launch of PatientGPT, a large language model trained on global patient experience data for the life sciences. This new model is the first of its kind and provides a revolutionary approach to drug development. The technology has been developed by Semalytix and can replace [...]The post Semalytix's PatientGPT to Reduce Six Months of Life Science Evidence & Insight Generation to Seconds first appeared on BusinessMole.